4//SEC Filing
McClung David Mark 4
Accession 0001209191-22-014167
CIK 0001001233other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 5:17 PM ET
Size
10.8 KB
Accession
0001209191-22-014167
Insider Transaction Report
Form 4
McClung David Mark
EVP Chief Business Officer
Transactions
- Tax Payment
Common Stock
2022-02-25$5.90/sh−4,610$27,199→ 125,584 total - Award
Common Stock
2022-02-25+59,400→ 184,984 total - Award
Stock Option (Right to Buy)
2022-02-25+160,380→ 160,380 totalExercise: $5.90Exp: 2032-02-24→ Common Stock (160,380 underlying)
Footnotes (5)
- [F1]Represents shares underlying the portion of a restricted stock unit ("RSU") grant that vested on February 25, 2022 which were surrendered by the Reporting Person to the Issuer for tax withholding using the Issuer's closing stock price on February 25, 2022 of $5.90/share, pursuant to the terms of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended (the "2018 EIP").
- [F2]Includes: (a) 8,722 shares resulting from the February 25, 2022 vesting of the Reporting Person's February 25, 2021 RSU grant and 26,668 shares subject to such RSU grant that will vest in two remaining annual installments of 13,332 shares and 13,336 shares on February 25, 2023 and 2024, respectively, and (b) 66,670 shares subject to the Reporting Person's June 25, 2020 RSU grant that will vest in two remaining annual installments of 33,330 shares and 33,340 shares on June 25, 2022 and 2023, respectively. The vesting of all such RSU grants is subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
- [F3]Includes 900 shares acquired on November 30, 2021 under the Issuer's 2020 Employee Stock Purchase Plan.
- [F4]Represents shares of common stock issuable upon settlement of an RSU grant that will vest as to one-quarter (1/4) of the shares on the first anniversary of the grant date, and the remainder of the shares will vest in 8 successive equal quarterly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
- [F5]One-quarter (1/4) of the shares subject to the option will vest and become exercisable on the first anniversary of the grant date, and the remainder of the shares will vest and become exercisable in 24 successive equal monthly installments thereafter, subject to the Reporting Person's Continuous Service (as defined in the 2018 EIP) through each such date and subject to acceleration as provided in the 2018 EIP.
Documents
Issuer
SANGAMO THERAPEUTICS, INC
CIK 0001001233
Entity typeother
Related Parties
1- filerCIK 0001811505
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 5:17 PM ET
- Size
- 10.8 KB